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Intravenous sodium fluorescein enhances
the visibility of vitreous during vitrectomy
surgery for diabetic retinopathy
Fluoresceína sódica intravenosa aumenta
a visibilidade do vítreo durante a cirurgia de
vitrectomia para retinopatia diabética
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ABSTRACT
Objective: To observe the effectiveness of intravenous sodium fluorescein visibility in
the vitreous during vitrectomy surgery in patients with diabetic retinopathy. Methods:
Fourteen consecutive cases of vitreoretinal surgery for vitreous hemorrhage and
tractional retinal detachment secondary to diabetic retinopathy underwent intravenous
injection of sodium fluorescein to 20% 1 hour before the surgery. The images of the steps
of the surgeries were recorded. Results: The sodium fluorescein stained green from the
vitreous peripheral, vitreous base, posterior hyaloid, further improving visibility to a
complete and more secure vitrectomy. The sodium fluorescein  also stained fibrous
points (sites of neovascularization) with high intensity making it easier its visibility. No
complications associated with the dye injection were observed in all cases. Conclusion:
Intravenous sodium fluorescein can be used safely for facilitating the observation of the
vitreous, vitreous base, posterior hyaloid and sites of neovascularization. This technique
can facilitate the process of vitrectomy in patients with diabetic retinopathy
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INTRODUCTION
V itrectomy is the treatment of choice forproliferative diabetic retinopathy with tractionor  persistent  vitreous hemorrhage (1). It can
frequently restore useful vision in diabetic patients and
reduce the risk of visual loss from traction retinal de-
tachment  (2).
The use of dilute sterile sodium fluorescein
(NaFl) has  previously  been  suggested as an aid in
vitrectomy (3-4). Except for two published letters (3-4), there
are no large studies describing the safety and efficacy of
intravitreal NaFl in vitreous surgery. However, there is
a study that described the safety and efficacy to use
Intravitreal sodium fluorescein to enhance the visibility
of  clear vitreous during vitreous surgery for macular
hole (5).
We  will  describe in this paper the efficacy of
Intravenous NaFl for enhances of visibility of vitreous
during vitrectomy surgery for diabetic retinopathy.
METHODS
Fourteen consecutive vitreoretinal surgery
cases for vitreous hemorrhage and tractional retinal
detachment,  secondary  to diabetic retinopathy, were
submitted  to  intravenous  sodium  fluorescein  20%
injection 1 hour previously the surgery (Table 1).
Surgery  was  performed  under  peribulbar anesthesia
by a single surgeon (R.C.S). Standard Three-port Pars
Plana Vitrectomy was performed using Accurus
vitrectomy machine (Alcon, Fort Worth, Texas, USA) with
the sclerotomies placed 4 mm (phakic eyes) or 3.5 mm
(aphakic and pseudophakic eyes) posterior to the lim-
bus. We do not use special filter to observe the contrast.
Limited core vitrectomy and removal of the vit-
reous close to the sclerotomy used for the insertion of the
vitreous cutter were initially performed. In phakic eyes,
in order to avoid direct trauma to the lens caused by the
vitrectomy instruments, vitrectomy at the vitreous base
from the 6 to 12 O’clock position was performed with the
vitreous cutter held by the right hand, and from the 12 to
6 O’clock position was performed with the left hand.
Initially, the central vitreous was removed (core
vitrectomy), followed by peeling of dense epiretinal
membranes. Vitreous shaving was performed with scleral
indentation  by an assistant using a muscle hook. The
images of all  surgery steps were recorded. Finally, the
retina was inspected by indirect ophthalmoscope and
fluid-gas exchange completed the procedure.
RESULTS
The  study  group  consisted of 14 diabetic
retinopathy patients. Fluorescein stained the pe-
ripheral uncut clear vitreous  green, vitreous  base,
posterior hyaloid and improved the visibility in all
instances.
At surgery time fluorescein stained the whole vit-
reous (Figure 1A), especially the vitreous base and the
posterior hyaloid in the posterior pole. Fluorescein also
stained  fibrous  points  (neovascularization  sites)
with stronger  intensity  making  it  easier  these  ar-
eas  observation (Figure 1 D).
At vitreous base shaving, fluorescein helped in
the  visualization even of the retina vitreous junction,
following the traction movements of the vitreous when
the vitrectomy probe gets closer from the retina, and
evidencing the limits of vitreous base with the periph-
ery retina, reducing the incidence of iatrogenic periph-
ery tears. During posterior hyaloid detachment proce-
dure, it was possible to see the hyaloid and the adherent’s
areas (Figure 1 B,C).
There was no stain of the lens or capsule
(pseudophakic) during surgery, and it was possible to
notice  that flourescein stained the anterior chamber,
especially at pseudophakic patients, but did not af-
fected the vitreous observation, not interfering at
vitrectomy. No complications associated with the dye
injection were observed in all cases.
Figure 1: A - View of the mid periphery showing uncut green coloured
vitreous gel  stained with sodium fluorescein during vitreous surgery;
B,C - Posterior hyaloid detachment procedure, it was possible to see
the hyaloid and the adherent’s areas; D - Fluorescein stained fibrous
points (neovascularization sites) with highly intensity making it easier
these areas observation
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DISCUSSION
The  vitrectomy  has  shown an increase in its
statement due to technical improvement mainly through
better performance of equipment, speed cutting and in-
creased less invasive systems (small gauge). One of the
new  tools  of  vitrectomy  are substances capable of
dyeing the structures intraocular facilitating visibility.
Some dyes have been well studied as indocyanine green
(ICG), trypan  blue  and  more  recently  the sodium
fluorescein (6-10).
In order to avoid the eye toxicity and also greater
manipulation during surgery (injection and aspiration
of the dye), we evaluated in this study the possibility of
the use of intravenous sodium fluorescein to as a dye for
use in vitrectomy.
In  this  study we used the intravenous sodium
fluorescein one hour before surgery in order to improve
the visibility of areas of interest during surgery for
vitrectomy in patients with diabetic retinopathy. We chose
this group of patients because they show a drop of blood-
retinal  barrier  thus facilitating the leak of f sodium
fluorescein  for vitreous cavity. The patients who were
included  in  this study had diabetic retinopathy with
vitreous hemorrhage (9 patients) and tractional retinal
detachment (7 patients).
We observed that the sodium fluorescein stained
the vitreous body, vitreous base, posterior hyaloid and
sites of neovascularization.
There was no need to use any special filter for
viewing the contrast. In all patients, the color green was
the sodium fluorescein observed with ease and especially
when put the light pipe near the area to be examined.
To remove the posterior hyaloid with active aspi-
ration, we observe that the sodium fluorescein provided
a clear vision of the posterior hyaloid moved. We also
observed that the sites of neovascularization became
impregnated by sodium fluorescein. This facilitated the
prevention of bleeding during the removal of posterior
hyaloid.
Another feature of intravenous sodium fluores-
cein is that there was no impregnation of the lens or the
posterior capsule in pseudophakic eyes. This fact is one
more advantage compared to other dye such as trypan
Patient Age Sex Retinal Vitreous Visual Visual IOP IOP Complication Lens status Follow up
status  status acuity acuity preop postop related to (months)
preop postop fluorescein
1 54 M TRD VH CF LP 12 62 No Phakic 7
2 36 M ERM VH HM 20/400 10 14 No Phakic 7
3 75 F Without VH 20/60 20/30 14 11 No Phakic 8
 TRD
4 36 M TRD clear CF CF 13 32 No Phakic 4
5 29 F TRD clear 20/30 20/80 14 44 No Pseudophakic 9
6 32 M Without VH HM 20/80 15 13 No pseudophakic 6
TRD
7 38 F Without VH CF 20/60 15 16 No phakic 2
TRD
8 43 M ERM Clear CF 20/150 16 50 No phakic 6
without
TRD
9 83 F TRD VH 20/100 20/80 12 18 No Pseudophakic 6
10 27 F TRD clear 20/60 20/100 14 54 No Phakic 4
11 69 M Without VH 20/200 CF 12 10 No Aphacik 4
TRD
12 67 F  TRD VH HM CF 14 16 No Phacik 7
13 51 M Without VH 20/100 20/30 15 19 No Pseudophakic 5
TRD
14 15 F TRD clear 20/25 20/200 13 16 No Phakic 5
Legend:  LP - light perception; CF -  finger counting; HM - hand movements; TRD - Tractional retinal detachment; VH -  vitreous hemorrhage; ERM - epiretinal
membrane
Table 1
Results of the vitreoretinal surgery for vitreous hemorrhage and tractional retinal detachment secondary
to diabetic retinopathy underwent intravenous injection of fluorescein to 20% 1 hour before the surgery
Visual acuity is best-corrected Snellen acuity
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blue  that  can  lead to impregnation of the posterior
capsule and subsequent worsening of visibility.
There was greater impregnating the vitreous
base compared with the central vitreous, facilitating the
vitreous shaving.
The intravenous sodium fluorescein may be a
good tool to get vitreoretinal surgery in patients with
diabetic retinopathy. Meanwhile a greater number
of  cases  will  need to assess the real benefit of this
technique
RESUMO
Objetivo: Observar a eficácia da fluoresceína sódica
intravenosa, na visibilidade do vítreo, durante a cirurgia
de vitrectomia nos pacientes com retinopatia diabética.
Métodos: Quatorze casos consecutivos de cirurgia
vitreorretiniana para hemorragia vítrea e descolamento
tracional da retina secundário à retinopatia diabética,
foram submetidos à injeção de fluoresceína intravenosa
a 20%, 1 hora antes da cirurgia.As imagens de todos os
passos das cirurgias foram gravadas. Resultados:  A
fluoresceína corou de verde o vítreo periférico, base ví-
trea, hialóide posterior melhorando a visibilidade para
uma vitrectomia completa e mais segura. A fluoresceína
também corou pontos fibrosos (sítios de
neovascularização) com alta intensidade tornando mais
fácil sua observação. Nenhuma complicação associada
com a injeção do contraste foi observada. Conclusão:
Fluoresceína sódica intravenosa pode ser usada de forma
segura para facilitar a observação do vítreo, base vítrea,
hialóide posterior e sítios de neovascularização. Esta téc-
nica pode facilitar o procedimento de vitrectomia em pa-
cientes com retinopatia diabética.
Descritores: Fluoresceína; Retinopatia diabética;
Vitrectomia
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